Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3695850012 | Dinoprostone 400 microgram/mL vaginal gel | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3695851011 | Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46714301000001112 | Dinoprostone 400micrograms/ml vaginal gel | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 58643301000001114 | Dinoprostone 1mg/2.5ml vaginal gel | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Is a | Product containing dinoprostone in vaginal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has active ingredient | Prostaglandin PGE>2< | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has active ingredient | Prostaglandin E>1< | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has active ingredient | Dinoprostone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has active ingredient | Posterior pituitary hormone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has active ingredient | Alprostadil | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has manufactured dose form | Vaginal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has manufactured dose form | Conventional release vaginal gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has basis of strength substance | Dinoprostone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has precise active ingredient | Dinoprostone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has concentration strength numerator value | 400 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Is a | Product containing only dinoprostone in vaginal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Plays role | Oxytocic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has manufactured dose form | Conventional release vaginal gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has manufactured dose form | Vaginal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Is a | Dinoprostone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has active ingredient | Dinoprostone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Vaginal route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | gel.vaginal ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has manufactured dose form | Conventional release vaginal gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has manufactured dose form | Conventional release vaginal gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has specific active ingredient | Dinoprostone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has dispensed dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Has dispensed dose form | Conventional release vaginal gel | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dinoprostone 1mg/2.5mL vaginal gel - product | Is a | False | Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Inferred relationship | Existential restriction modifier | |
| Prostin E2 1mg vaginal gel (Pfizer Ltd) | Is a | True | Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Inferred relationship | Existential restriction modifier | |
| Dinoprostone 400micrograms/ml vaginal gel 2.5 ml | Is pack of | False | Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Inferred relationship | Existential restriction modifier | |
| Dinoprostone 400micrograms/ml vaginal gel 2.5 ml | Has VMP | True | Product containing precisely dinoprostone 400 microgram/1 milliliter conventional release vaginal gel | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR